Sander J O Veldhuyzen van Zanten
Affiliation: University of Alberta
- A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN StudySander J O Veldhuyzen van Zanten
Division of Gastroenterology, Dalhousie University, Halifax, Nova Scotia, Canada
Am J Gastroenterol 100:1477-88. 2005..The management of Helicobacter pylori negative patients with dyspepsia in primary care has not been studied in placebo-controlled studies...
- Pitfalls in designing trials of functional dyspepsia: the ascent and demise of itoprideSander J O Veldhuyzen van Zanten
Division of Gastroenterology, University of Alberta, Zeidler Ledcor Centre, Edmonton, Alberta T6G 2X8, Canada
Gut 57:723-4. 2008
- Patient satisfaction with medication for gastroesophageal reflux disease: a systematic reviewSander Jo van Zanten
University of Alberta, Edmonton, Alberta, Canada
Can J Gastroenterol 26:196-204. 2012..Patient satisfaction is increasingly regarded as an important aspect of measuring treatment success in individuals with gastroesophageal reflux disease (GERD)...
- Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II studyS Veldhuyzen van Zanten
Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Aliment Pharmacol Ther 34:714-23. 2011..Patients with dyspepsia often experience troublesome symptoms...
- Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infectionSander Veldhuyzen van Zanten
Division of Gastroenterology, University of Alberta, Edmonton Centre, Edmonton, Alberta
Can J Gastroenterol 24:303-6. 2010..To evaluate the efficacy of rescue therapy using rifabutin, amoxicillin and a proton pump inhibitor (PPI) in the eradication of Helicobacter pylori in patients who have failed at least one course of PPI-based triple therapy...
- Systematic review of the quality of patient information on the internet regarding inflammatory bowel disease treatmentsMorgan Langille
Division of Otolaryngology Head and Neck Surgery, University of Alberta, Edmonton, Canada
Clin Gastroenterol Hepatol 8:322-8. 2010..A systematic review evaluating the quality of information available for inflammatory bowel disease patients on the Internet regarding treatment options was performed...
- Gastric ulcer treatment: cure of Helicobacter pylori infection without subsequent acid-suppressive therapy: is it effective?Sander Veldhuyzen van Zanten
Division of Gastroenterology, University of Alberta, Zeidler Ledcor Centre, Edmonton, Alberta, Canada
Eur J Gastroenterol Hepatol 20:489-91. 2008..This is certainly recommended when dealing with bleeding ulcers...
- Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaireS V Van Zanten
Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada
Aliment Pharmacol Ther 25:1087-97. 2007..The reflux disease questionnaire (RDQ) is a short, patient-completed instrument...
- Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management toolSander J O Veldhuyzen van Zanten
Division of Gastroenterology, Dalhousie Medical School, Dalhousie University, Queen Elizabeth II Health Sciences Centre, 1278 Tower Road, Halifax, Nova Scotia B3H 2Y9, Canada
Can J Gastroenterol 19:285-303. 2005..When starting nonsteroidal anti-inflammatory drugs for a prolonged course, testing and treatment with H2RAs are advised if patients have a history of previous ulcers or ulcer bleeding...
- Design of treatment trials for functional gastrointestinal disordersE Jan Irvine
Division of Gastroenterology, St Michael s Hospital and University of Toronto, Toronto, Ontario, Canada
Gastroenterology 130:1538-51. 2006..Trials should be registered in a public location, prior to initiation, and should be published even if the results are negative or inconclusive...